DexCom, Inc.
$63.4
▲
1.28%
2026-04-22 10:12:13
www.dexcom.com
NMS: DXCM
Explore DexCom, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$24.57 B
Current Price
$63.4
52W High / Low
$89.98 / $54.11
Stock P/E
30.77
Book Value
$7.14
Dividend Yield
—
ROCE
21.72%
ROE
34.5%
Face Value
—
EPS
$2.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
11,000
Beta
1.56
Debt / Equity
50.85
Current Ratio
1.88
Quick Ratio
1.59
Forward P/E
21.39
Price / Sales
5.36
Enterprise Value
$24.04 B
EV / EBITDA
20.66
EV / Revenue
5.16
Rating
Strong Buy
Target Price
$87.08
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 2. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 3. | Establishment Labs Holdings Inc. | $66.93 | — | $1.96 B | — | -14.18% | -1.33% | $83.31 / $28.67 | $0.8 |
| 4. | IceCure Medical Ltd | $0.36 | — | $24.87 M | — | -166.53% | -1.89% | $1.4 / $0.28 | $0.12 |
| 5. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 6. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 7. | OrthoPediatrics Corp. | $16.65 | — | $420.89 M | — | -6.27% | -11.31% | $23.7 / $14.91 | $13.81 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 1.26 B | 1.21 B | 1.16 B | 1.04 B | 1.11 B |
| Operating Profit | 323 M | 242.5 M | 212.6 M | 133.7 M | 188.9 M |
| Net Profit | 267.3 M | 283.8 M | 179.8 M | 105.4 M | 151.7 M |
| EPS in Rs | 0.69 | 0.74 | 0.47 | 0.27 | 0.39 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.66 B | 4.03 B | 3.62 B | 2.91 B |
| Operating Profit | 911.8 M | 600 M | 597.7 M | 391.2 M |
| Net Profit | 836.3 M | 576.2 M | 541.5 M | 341.2 M |
| EPS in Rs | 2.17 | 1.5 | 1.41 | 0.89 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.34 B | 6.48 B | 6.26 B | 5.39 B |
| Total Liabilities | 3.59 B | 4.38 B | 4.2 B | 3.26 B |
| Equity | 2.75 B | 2.1 B | 2.07 B | 2.13 B |
| Current Assets | 4.03 B | 4.3 B | 4.43 B | 3.67 B |
| Current Liabilities | 2.14 B | 2.93 B | 1.56 B | 1.84 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.44 B | 989.5 M | 748.5 M | 669.5 M |
| Investing CF | 536 M | -207.5 M | -507.2 M | -521.5 M |
| Financing CF | -1.69 B | -734.8 M | -318.6 M | -552.5 M |
| Free CF | 1.08 B | 630.7 M | 511.9 M | 304.7 M |
| Capex | -363.5 M | -358.8 M | -236.6 M | -364.8 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.34% | 24.49% | — | — |
| Earnings Growth % | 6.41% | 58.7% | — | — |
| Profit Margin % | 14.29% | 14.95% | 11.73% | — |
| Operating Margin % | 14.88% | 16.5% | 13.44% | — |
| Gross Margin % | 60.46% | 63.19% | 64.72% | — |
| EBITDA Margin % | 23.45% | 25.31% | 19.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-06-13 | 1:4 |